(2β,3α,5α,16β,17β)-2,16-dipiperidin-1-ylandrosta-3,17 diol

Warning

EC Number

236-866-3

CAS Number

13522-16-2

Formula

C29H50N2O2

Hazard Classification

Harmonised EU classification under CLP Regulation.

H302+H312+H332: Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]; H302: Harmful if swallowed [Warning Acute toxicity, oral]; H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H332: Harmful if inhaled [Warning Acute toxicity, inhalation]

Regulatory Status

SVHC (Candidate List)

Authorisation Required

Restricted

Is (2β,3α,5α,16β,17β)-2,16-dipiperidin-1-ylandrosta-3,17 diol banned in the EU?

No specific ban or restriction. Check current ECHA records for the latest status.

External Resources

PubChem

Related Substances

1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8-iodononane 38550-34-4 Warning (4-bromophenoxy)trimethylsilane 17878-44-3 Warning (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate 989-51-5 Warning (±)-2-amino-4,4,4-trifluoro-3-(trifluoromethyl)butyric acid 16063-80-2 Warning (Z)-hex-3-enyl lactate 61931-81-5 Warning 1,1,3,3-tetramethylindan-5-ol 53718-26-6 Warning

Data sourced from the European Chemicals Agency (ECHA). Information is provided for reference only. Always consult official ECHA records and relevant Safety Data Sheets for regulatory compliance.